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Abstract Background: The cost 
of taking care of children with 
acute kidney injury (AKI) is enor-
mous and beyond the reach of 
many caregivers in sub-Saharan 
Africa which are largely resource 
poor. It is therefore imperative to 
determine those who may benefit 
from conservative management 
which is comparatively cheaper to 
the renal replacement therapy 
(RRT). 
Objectives: To determine the 
clinical characteristics of children 
who were offered conservative 
and renal replacement therapy and 
evolve the most statistically  
significant eligibility criteria.  
Methods: A descriptive cross-
sectional study of children pre-
senting with AKI admitted into 
the Emergency Paediatric Unit 
(EPU) of the University of Ilorin 
Teaching Hospital (UITH)  
between January 2008 to Decem-
ber 2012 was carried out.   Demo-
graphic, clinical, and laboratory 
data were collected. A serial 
blood chemistry and urine  
analysis were also obtained.  A 
total of 22 cases of acute kidney 
injury were seen within the period. 
Fourteen were conservatively 
managed while eight underwent 
sessions of dialysis.  
Results: The age range for those 
who had conservative management 
was 4-17 years with a mean ±SD 
of 8.11±3.91 years while the corre-
sponding value in those with renal 
replacement therapy was 1.5-16 
years with a mean ±SD of 
9.68±5.54years. There was no sta-
tistical significant difference in the 
highest serum potassium, urea and 
creatinine. However, the lowest 
urine output was significantly dif-
ferent among the two groups  
(p< 0.05). 
Conclusion: Urine output could be 
used as an eligibility criterion to 
determine children with AKI who 
will require renal replacement 
therapy or benefit from a trial of 
conservative management.   
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Introduction 
 
Definitions for AKI vary widely between studies, rang-
ing from absolute or relative increases in creatinine from 
baseline to the requirement for RRT.1-2 The lack of a 
uniform definition may explain the large differences in 
reported incidence and outcomes of AKI in the litera u e 
1, and as a consequence in 2004, a consensus on the defi-
nition of acute renal failure known as the Risk-Injury-
Failure-Loss-End stage renal disease (RIFLE) classifica-
tion was reached by a group of international experts.1 
The RIFLE classification was based on two important 
parameters, changes in serum creatinine or GFR from
baseline  and  urine output at specific time points. The 
severity of acute renal failure was determined by the
more severe of the two parameters, which were catego-
rized into three stages. The three stages described in 
RIFLE include Risk, Injury and Loss, all of which have 
increasing prognostic significance. 
 
In 2007, the Acute Kidney Injury Network (AKIN)  
replaced the term acute renal failure with acute kidney 
injury (AKI) in an attempt to include the entire spectrum 
of acute renal dysfunction.3 AKI encompasses a  
complex clinical entity characterized by an abrupt  
decline in kidney function which clinically manifests as 
azotemia, rising serum creatinine, and in most cases 
oliguria. 4-5 Furthermore, AKI continues to be associated 
with significant mortality, hospital length of stay and 
economic costs, particularly in the context of criti ally 
ill patients in the intensive care setting.6-7 
Although the incidence of AKI continues to rise, the 
optimum management of AKI remains uncertain with no 
uniform standard of care, as reflected by wide disparity 
in clinical practice.8-10 This is aside from the fact that the 
management of AKI can be most challenging in  
resource poor countries of Africa where management 
can be anything but ideal.11 This is because resources 
are inadequate and the people living below the poverty 
line are too many. Furthermore, people have to pay out 
of pocket to procure urgent services.11 In this circum-
stance, it would be unwise to offer expensive  
management first. Rather it is instructive to identify 
those predictive factors that will help anticipate those 
who will respond to less invasive and costly treatment 
such as conservative management. Hence this study 
aims to determine eligibility criteria to determine chil-
dren with AKI who could benefit from conservative 






A descriptive cross sectional study of children present-
ing with features suggestive of AKI admitted into the 
Emergency Paediatric Unit (EPU) of the University of 
Ilorin Teaching hospital, Ilorin, Nigeria was carried out 
between January 2008-December 2012. Informations 
obtained on them included; age, sex, cause of AKI,  
lowest urine output over 24 hours in ml/kg /hr during 
admission, the highest serum potassium, urea and 
creatinine and the lowest sodium. These parameters 
were then compared in those that received conservative 
management and those that had to be placed on dialysis. 
The inclusion criteria included reduced GFR, oligura, 
anuria, oedema, raised serum creatinine and urea. R-
duced GFR is GFR less than standard value for age.12 
Hypertension is elevated blood pressure above the 90th 
percentile for age and sex.13 oliguria is urine output be-
low 300mls/m2 or 1ml/kg/hr, while anuria is urine out-
put less than 1ml/kg/day.14 Serum creatinine and urea 
are raised when the values are above standard values for 
age groups e.g. >62µmol/l for non-adolescent children 
and > 88µmol/l for adolescents. Serum urea is raised 
when it is  >6.4 mmol/l.15 
 
The conservative management group comprised of those 
managed with fluid challenge, fluid restriction, control 
of hyperkalemia, acidosis, hypocalcaemia, anemia and 
hypertension. Hypertension was controlled with capto-
pril (0.5mg/kg/dose 8hourly (maximum dose 6mg/
kg/24hours) and nifedipine (0.5mg/kg/dose 12hourly 
(maximum dose 3mg/kg/24hrs). Hyperkalemia was 
managed with restriction of potassium containing food, 
fluid and medication.  The type of dialysis offered in our 
center was only haemodialysis and no peritoneal dialysis 
as there was no peritoneal fluid available. There was no 
exact randomization to any specific treatment rather t y 
were need or fund driven. In other words, some of th se 
who were offered dialysis based on our clinical judg-
ment continued on conservative management, while 
awaiting availability of fund. In a few cases, there was 
remarkable improvement which obviated the further 
need for dialysis. Similarly, some of those who were 
considered eligible for conservative management but 
who deteriorated were commenced on dialysis. 
The sensitivity, specificity, positive and negative pr dic-
ive value of parameters found to be significant was  
calculated. To aid the calculation, the  patients were 
categorized into true positives and negatives and false 
positives and negatives respectively. True positives (TP) 
are those who rightly  received corresponding approri-
ate management using the significant parameter. True 
negatives (TN) are those who did not rightly receive the 
corresponding appropriate management using the  
significant parameter. False negatives (FN) are those 
who  did not receive inappropriate corresponding  
management  using the significant parameter and false 
positives (FP) are those who received inappropriate 
management using the significant parameter.  
Hence sensitivity is (TP/TP+FN) X 100%.  Specificity is 
(TN/TN+FP) X 100%. Positive predictive value is (TP/
TP+FP) X 100%. Negative predictive value is (TN/






A total of 22 patients were recruited for the study.  Their 
age range was 1.5-17 years. There were 11 males and 11 
females giving a male female ratio of 1:1. Fourteen 
(63.6%) received conservative management while 8
(36.4%) of them received dialysis. Three of those who 
received dialysis were referred to sister institutions  and 
word reaching us indicated that they all died. One of 
those that benefited from conservative management was 
also referred to a sister institution for dialysis but recov-
ered fully there, without it.  Five of the eight patients 
that received dialysis did so in our center. They all re-
ceived haemodialysis. The age range for those who had 
conservative management was 4-17 years with a 
mean±SD of 8.11±3.91 years, while the corresponding 
value in those who received dialysis was 1.5- 16 years 
with a mean ±SD of 9.68±5.54 years.  
 
The leading cause of AKI in the conservative manage-
ment group was severe malaria with haemoglobinuria 
which resulted in acute tubular necrosis (ATN) in 6 
(42.9%) followed by sepsis in 4(28.5%). The leading 
causes in the dialysis group was Acute glomerulonephri-
tis (AGN) with uraemic encephalopathy in 4(50%)  
followed by sepsis in 2(25%) (Table 1).  
 
Table 1: Causes and outcome of AKI in the study population 
Cause of AKI               Conservative group      Dialysis group 
                                           n-14                              n-8 
Malaria+hbnuria                     6                                   0 
Sepsis                                     4                             2
AGN                                       2                             4
Burkitt lymphoma                  1                              0 
Neuroblastoma                        1                               0 
Diarrhoeal disease                   0                           1 
Nephrotic syndrome                0                           1 
No. of deaths (%)               1(7.1%)                  4(50%) 
Causes of death           Burkitt Lyphoma     AGN+ uraemic  
                                          TLS(1)             encepahalopath (3) 
                                                            Diarrhoeal Disease(1) 
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AGN-acute glomerulonephritis, TLS-tumor lysis syndrome,  
hbnuria-haemoglobinuria 
 
The mean±SD of lowest urine output in the conservative 
management group was 0.63±0.40ml/kg/hr and the di-
alysis group was 0.12±0.09 ml/kg/hr respectively. The 
mean highest potassium in the conservative management 
group was 5.01±1.09mmol/l while it was 
5.41±0.95mmol/l in the dialysis group. The mean high-
est serum urea in the conservative management group 
was 38.05±13.60mmol/l, while that in the dialysis group 
was 43.86±14.88mmol/l. The mean serum creatinine in 
the conservative management group was 
692.5±507.15µmol/l, while that in the dialysis group 
was 1095.5±531.03µmol/l. The lowest serum sodium in 
the conservative management group was 126.21±6.91 
mmol/l, while it was 124.62±4.97mmol/l in the dialysis 
group (Table 4). The individual biochemical parameters 
of children who received conservative management and 
dialysis respectively are shown in Tables 2 and 3  
respectively.  
 
Table 2: Biochemical parameters in the conservative group 
SM-severe malaria, NB- neuroblastoma, BUR,-Burkitt lymphoma, 
SEP-Sepsis, AGN-acute glomerulonephritis 
 
 
Table 3: Biochemical parameters in the dialyzed group 
AGN-acute glomerulonephritis, NS-nephrotic syndrome, SEP-sepsis, 
DIA-diarrhea 
 
When all the parameters were compared in both groups, 
only the lowest urine output was found to significantly 
predict whether dialysis or conservative management 
would be required (p<0.05). While the highest serum 
creatinine, urea and potassium were found to be higher 
in the dialysis group, it was found not to be statiically 
significant. Similarly the lowest serum sodium was 
found to be lower in the dialysis group but it was not 
statistically significant (Table 4). 
Patient Age  Sex   Cause   Lowest  highest   Cr highest  highest K lowest outcome 
                                              U/o     Umol/l   urea mmol/l  mmol/l   Na mmol/l 
C1.       4        M    SM          0.5        542          27              6.7          113       Alive 
C2.       5        M    SM          1           421          22.3           4.7          118       Alive 
C3.       9        M    NB          0.48      248          26.4           4.1          132       Alive 
C4.       17      F     AGN       0.7        220       19.9            4.4          132       Alive 
C5.       10      F      SM         1.2        1824        59              4.8          129       Alive 
C6.       5        F      SEP        1.4        315         46.1           7.0          128       Alive 
C7.       7        M    SEP         0.48      296          28.6           3.5          136       Alive 
C8.       13      F      BUR       0.2        222        39.2           3.7          122       Died 
C9.       5        M    SM          0.3        789          53.9           3.8          130       Alive 
C10.     6.5     M    SM          0.8        1079      44.2           5.9          121       Alive 
C11.     5        M    SEP         0.7        210          18.8           4.5          127       Alive 
C12.     6        M    SM          0.01      929       42.3           6.3          132       Alive 
C13.     13      F     SEP         0.82      1520       46.7           5.3          129       Alive 
C14.     6        M    AGN        0.2       1080        58.3           5.5          115       Alive 
  
Patient Age Sex  Cause  lowest  highest   Cr highest   highest K  lowest outcome 
                                         U/O     Umol/l    urea mmol/l  mmol/l   Na mmol/l 
D1.        9      F    AGN   0.16      1450         73.7             5.0           121       Died 
D2.      1.5     M   AGN   0.06      342           27.5             5.4           118       Died 
D3.       11     F    AGN    0.1       1998         45                5.3           127       Died 
D4.       16     F     NS      0.3       1013      29.4             6.0           127       Alive 
D5.       14     F    AGN   0.02      1655         46.5             6.7           130       Alive 
D6.       15     F    SEP     0.01      981        58                4.9           131       Alive 
D7.        2      M   DIA    0.08      521         30.2              3.5          126       Died 
D8.        9      F    SEP     0.2        804           40.6             6.5           117       Alive 
Table 4: Clinical and biochemical determinants of modality of  
treatment 
 
The mean lowest urine output (when approximated to 
one decimal place) in the dialysis group was 0.1±0. ml/
kg/hr compared to 0.6ml±0.4/kg/hr in the conservative 
group. When  the urine output benchmark of  ≥0.6ml/kg/
hr for conservative group and ≤0.1ml/kg/hr for dialysis 
group was used amongst all the 22 patient to determin  
eligibility for either conservative or renal replacement 
therapy,  true positives (i.e. those who rightly received 
the corresponding appropriate management i.e. conser-
vative management  for children with  urine output 
≥0.6mls/kg/hr  and  dialysis for children with urine out-
put  ≤0.1ml/kg/hr)  were 12 patients, true negative (those 
who did not rightly receive the corresponding approri-
ate management using the urine output eligibility crite-
ria) 10 patients, false positive (those who received   
corresponding inappropriate management using the 
urine output eligibility criteria) 10 patients, false nega-
tive (those who did not receive corresponding inappro-
priate management using the urine output eligibility 
criteria) 12 patients. Hence the sensitivity, specificity , 
positive predictive value and negative predictive value 
using the urine as eligibility criteria for choice of modal-
ity of management  was 50%, 50%,37.5% and 31.2%  
respectively. 
 
The outcome was better in the conservative group which 
recorded one death out of a total of 14 patients (7.14%) 
compared to 4 deaths amongst 8 patients managed with 
dialysis (50%).  Most of the deaths 3(75%) recorded 
among the dialysis group were due to AGN with urae-
mic encephalopathy with the rest being due to AKI from 
diarrhoeal diseases. The only death recorded in the con-
servative group was in a child with Burkitt lymphoma 
who developed AKI from Tumor lysis syndrome. Even 
then, the death was not as a result of AKI as all the pa-
rameters had improved before his death. The overall 







AKI is one of the causes of childhood morbidity and 
mortality.16-17 This follows some of the major childhood 
conditions in the tropics such as malaria and sepsi.11-12 
The kidney is not spared in the fatal progression of these 
two illnesses as seen in the causes of the AKI in this 
series. It is however gratifying to note that most f hem 
responded to conservative management. Indeed, most of 
the AKI resulting from malaria subsided after conserva-
Parameter      Conservative     Dialyzed           t               p 
                       Mean±SD        Mean±SD 
                         n=14                  n=8 
Lowest urine  0.63±0.40         0.12±0.09          -3.094        0.006 
Highest Cr     692.5±507.15   1095.5±531.03    1.709        0.103 
Highest Urea  38.05±13.60     43.86±14.88       0.945        0.354 
Highest  K       5.01±1.09         5.41±0.95       0.823        0.420 
Lowest Na     126.21±6.91      124.62±4.97     -0.381        0.707 
397 
tive management with none requiring dialysis. It is 
likely that the appropriate treatment of the underlying 
malaria contributed to this good outcome.  Similarly, the 
use of appropriate antibiotics to treat sepsis would have 
also contributed to the good outcome. The bottom line
therefore is that the fatal progression of these two ill-
nesses can be interrupted with the use of appropriate 
potent pharmacologic agents. Once this is done, the con-
sequent AKI is reversed in most cases if acute cortical 
necrosis has not developed.  
 
In contrast, renal replacement therapy was required in 
the glomerulopathies whose course sometimes carry 
poor prognosis once AKI sets in.18 The causes of AKI in 
the glomerulopathies may include the disease process 
itself which are irreversible in some cases and the eff ct 
of drug used in the management of the condition such as 
frusemide which could cause interstitial nephritis. 
 
A close look at the serum creatinine of the conservative 
group shows that it was lower when compared with the 
dialysis group even though it was not statistically sig-
nificant. Hence as serum creatinine rises, the corre-
sponding most appropriate intervention must be offered 
immediately. However in resource poor countries of 
Africa, conservative management are more readily of-
fered because of limited facilities and uneven distribu-
tion and availability of renal replacement therapy.19 In 
Nigeria, the spread and availability of dialysis facilities 
is gradually improving. However there are still chal-
lenges of ability of caregivers to pay for the services and 
when they can pay, certain logistics may be unavail-
able.19-20 Our study indicated that offering conservative 
management may not be a bad option at serum 
creatinine ≤676.79µmol/l. However at serum creatinine 
>676.7µmol/l, dialysis remains the best option, even 
though there may still be a few patients that may benefit 
from conservative management as evidenced by six pa-
tients in Table 2 with elevated serum creatinine due 
mainly to severe malaria. As earlier indicated, AKI re-
verses in most cases of severe malaria once appropriate 
antimalaria is administered.  Similarly at serum urea 
≤37.34mmol/l, conservative management may be con-
sidered, while at serum urea above that, dialysis remains 
the best option. Mean serum potassium were on the  
higher level of normal in both the conservative and di-
alysis group  but the difference in both groups was not 
statistically  significant even though there were individ-
ual cases of hyperkalemia as shown in Tables 2&3. The 
serum sodium was comparably low in both groups be-
cause of the consequent fluid retention common to bo h
groups. Of all the biochemical determinants of modality 
of management, only serum creatinine may be consid-
ered in isolation. The others must be considered relativ  
to the serum creatinine. In other words, if the serum urea 
is elevated and the serum creatinine is not proportion-
ately elevated, it may be of no effect as other conditions 
such as dehydration may have contributed to that. 
 
The most significant determinant of modality of treat-
ment in this study was the urine output.  It had an appre-
ciable sensitivity and specificity, however, the positive 
and negative predictive value was marginal. This is in 
tandem with the RIFLE and AKIN recommendation 
which uses both (urine output and GFR) and (urine out-
put and serum creatinine) respectively as criteria for 
determining severity and hence mode of management of 
AKI. 1, 3 Therefore, if the mean lowest urine output in 
both groups (shown in Table 4) is approximated to one
decimal place, it would give (0.6±0.4ml/kg/hr for the 
conservative group) and (0.1±0.1 ml/kg/hr for the dialy-
sis group).  The implication therefore is that children 
with urine output of ≥0.6ml/kg/hr would benefit from 
conservative management, while children with urine 
output of ≤0.1ml/kg/hr would require dialysis.  
 
There is the group in between >0.1ml/kg/hr (benchmark 
for dialysis group) and <0.6ml/kg/hr (benchmark for the 
conservative group) i.e. 0.11-0.59ml/kg/hr which is left 
hanging. It is our opinion that  any urine output be ween 
0.11-0.59ml /kg/hr may be offered a “trial of  conserva-
tive management” when all other biochemical parame-
ters are considered. However to minimize risk to the 
patients, the best form of intervention available should 
be promptly offered. 
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